Magnocavallo, Michele
 Distribuzione geografica
Continente #
NA - Nord America 397
EU - Europa 168
AS - Asia 43
SA - Sud America 5
AF - Africa 2
OC - Oceania 1
Totale 616
Nazione #
US - Stati Uniti d'America 392
IT - Italia 96
SE - Svezia 41
IN - India 33
RO - Romania 9
TH - Thailandia 6
AR - Argentina 5
IE - Irlanda 5
NL - Olanda 5
CA - Canada 4
PL - Polonia 4
FR - Francia 3
CN - Cina 2
TG - Togo 2
UA - Ucraina 2
DE - Germania 1
DO - Repubblica Dominicana 1
GB - Regno Unito 1
ID - Indonesia 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
Totale 616
Città #
Chandler 61
Fairfield 59
Rome 43
Princeton 32
San Paolo di Civitate 24
Millbury 23
Wilmington 21
Ashburn 18
Woodbridge 15
San Diego 14
Seattle 14
Lawrence 13
Andover 12
Houston 12
Cambridge 11
Amsterdam 5
Dublin 5
Federal 5
Redwood City 5
Norwalk 4
San Mateo 4
Toronto 4
Boardman 3
Boston 3
Guidonia Montecelio 3
Matera 3
Ann Arbor 2
Biancavilla 2
Bologna 2
Buffalo 2
Corteno Golgi 2
Fremont 2
Laxou 2
Lomé 2
Milan 2
Mountain View 2
Sacramento 2
Auckland 1
Austin 1
Bangalore 1
Bergamo 1
Bussolengo 1
Hangzhou 1
Jakarta 1
Las Vegas 1
London 1
Marano Di Napoli 1
Marino 1
Milazzo 1
Plattsmouth 1
Redmond 1
Richmond 1
San Pablo 1
Santo Domingo Este 1
Serra D'aiello 1
Shenzhen 1
Strumica 1
Villanova 1
Totale 459
Nome #
Management of cardiac implantable electronic device follow-up in COVID-19 pandemic. Lessons learned during Italian lockdown 47
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis 41
Adverse drug reactions during real-life use of direct oral anticoagulants in italy. An update based on data from the italian national pharmacovigilance network 36
Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicenter experience during the covid-19 lockdown 34
Flecainide in ventricular arrhythmias. from old myths to new perspectives 32
Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease 31
Flecainide how and when. a practical guide in supraventricular arrhythmias 29
Potential role of eNOS genetic variants in ischemic heart disease susceptibility and clinical presentation 29
Sporadic high pacing and shock impedance on remote monitoring in hybrid implantable cardioverter-defibrillator systems: clinical impact and management 27
Thromboembolic and bleeding risk in atrial fibrillation patients with chronic kidney disease: role of anticoagulation therapy 26
Incidence of Device-Related Thrombosis in Watchman Patients Undergoing a Genotype-Guided Antithrombotic Strategy 26
New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation 25
Radiofrequency Energy Applications Targeting Significant Residual Leaks After Watchman Implantation: A Prospective, Multicenter Experience 23
Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion 21
Reply to the editor-high subthreshold pacing impedance from device-lead connection issues 20
A mobile app for improving the compliance with remote management of patients with cardiac implantable devices. a multicenter evaluation in clinical practice 19
Left atrial appendage exclusion in atrial fibrillation radiofrequency ablation during mitral valve surgery: a single-center experience 17
Clinical presentation, diagnosis, and treatment of atrioesophageal fistula resulting from atrial fibrillation ablation 16
Prevalence and clinical Implications of COVID-19 myocarditis 16
null 15
null 15
Predictive value of measures of vascular calcification burden and progression for risk of death in incident to dialysis patients 14
Targeting non-pulmonary vein triggers in persistent atrial fibrillation: results from a prospective, multicentre, observational registry 14
null 14
null 13
Procedural and Short-Term Follow-Up Outcomes of Amplatzer Amulet Occluder versus Watchman FLX Device: A Meta-Analysis 13
Clinical Support through Telemedicine in Heart Failure Outpatients during the COVID-19 Pandemic Period: Results of a 12-Months Follow Up 11
Catheter ablation of life-threatening ventricular arrhythmias in athletes 11
null 11
[Atrial fibrillation, oral anticoagulation and nephroprotection: caution or bravery?] 10
The scar. the wind in the perfect storm-insights into the mysterious living tissue originating ventricular arrhythmias 9
Vascular Calcification Progression Modulates the Risk Associated with Vascular Calcification Burden in Incident to Dialysis Patients 9
The scar: the wind in the perfect storm—insights into the mysterious living tissue originating ventricular arrhythmias 8
Prevalence, management, and outcome of atrial fibrillation and other supraventricular arrhythmias in COVID-19 patients 8
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 7
Catheter Ablation For Papillary Muscle Arrhythmias A Systematic Review 7
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 6
Impact of COVID-19 pandemic on cardiac electronic device management and role of remote monitoring 5
Clinical Support through Telemedicine in Heart Failure Outpatients during the COVID-19 Pandemic Period: Results of a 12-Months Follow Up 1
Rationale and study design of the Italian Registry in the setting of atrial fibrillation ablation with Rivaroxaban - IRIS 1
Totale 717
Categoria #
all - tutte 2108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0000 00 03 1219415
2021/2022350 512153 2324 852 38145655
2022/2023314 5953920 3824 1921 4612130
Totale 717